The Use of Ranolazine to Facilitate Electrical Cardioversion in Cardioversion‐Resistant Patients: A Case Series

201257 citationsJournal Article

Authors

Jeff Kaliebe · Cardiovascular Research Foundation

Abstract

RZ shows promise as a safe and convenient agent to facilitate EC in EC-resistant patients. It appears to be most effective in patients whose AF duration is known to be less than 3 months.

Topics & Keywords

Cardiac electrophysiology and arrhythmias Atrial Fibrillation Management and Outcomes Cardiac Arrhythmias and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Pacing and Clinical Electrophysiology

Volume 35, Issue 3, pp. 302-307

DOI: 10.1111/j.1540-8159.2011.03298.x

Field-Weighted Citation Impact: 4.84